戻る
Dri Healthcare Trust (DHTRF)価格
DHTRF 株価推移チャート
DHTRF 収入
Dri Healthcare Trust
$11.48
0%
$0
終値： Jan 22, 16:00:00 GMT-5
$11.48
0%
$0
アフターマーケット：Jan 22, 17:05:29 GMT-5
主要データ
前終値
$11.48
始値
$11.5
当日レンジ
$11.48 - $11.5
52週レンジ
$7.54 - $13.02
取引高
100
平均取引高
927
1株当たり利益(TTM)
0.07
配当利回り
--
時価総額
$632.6M
DHTRFとは何ですか？
DRI Healthcare Trust is an unincorporated open-ended company. The company is headquartered in Toronto, Ontario and currently employs 36 full-time employees. The company went IPO on 2021-02-11. The firm provides capital to universities and research institutions, academic institutions, biotechnology companies and pharmaceutical companies. The company has acquired more than 75 royalties on 45-plus drugs, including Ekterly, Eylea, Keytruda, Orserdu, Remicade, Spinraza, Stelara, Vonjo and Zytiga. Its portfolio includes Empaveli/Syfovre, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, and other products. Its therapeutic areas include oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, lysosomal storage disorders (LSD) and immunology. The Company’s products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; Vertex Pharmaceuticals; KalVista, Galderma and others.